Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.
Conceivable Life Sciences has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Conceivable Life Sciences's investors include Artis Ventures, Stride.VC, ACME Capital, Black Opal Ventures, Muse Capital.
Conceivable Life Sciences is headquartered in New York, United States.
Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.
Conceivable Life Sciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Conceivable Life Sciences — Funding & Investors." VCBacked, January 14, 2025, https://www.vcbacked.co/company/conceivable-life-sciences. Accessed July 21, 2026.
VCBacked. (2025). Conceivable Life Sciences — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/conceivable-life-sciences
{{cite web |title=Conceivable Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/conceivable-life-sciences |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated